Pharmaceutical raw material report system to apply for new items.

Published: 2002-06-20 06:57:00

Updated: 2002-06-20 06:57:00

The pharmaceutical raw material report system shall be enforced for the new chemical entity authorized by the KFDA from July 1 this year according to the KFDA's guideline of the pharmaceutical raw material report.

The new item was originally intended to include not only new drugs but also bio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK